245 related articles for article (PubMed ID: 6389091)
1. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
3. [Value of prazepam drops in the brief treatment of anxiety disorders].
Ansseau M; Von Frenckell R
Encephale; 1991; 17(4):291-4. PubMed ID: 1959497
[TBL] [Abstract][Full Text] [Related]
4. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
Dorman T
Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
[TBL] [Abstract][Full Text] [Related]
5. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
Pinosky DG
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
[TBL] [Abstract][Full Text] [Related]
6. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety].
Guelfi JD; Lancrenon S; Millet V
Encephale; 1993; 19(5):547-52. PubMed ID: 8306923
[TBL] [Abstract][Full Text] [Related]
7. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
Zung WW; Daniel JT; King RE; Moore DT
J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
[TBL] [Abstract][Full Text] [Related]
8. Prazepam and lorazepam, two new benzodiazepines.
Greenblatt DJ; Shader RI
N Engl J Med; 1978 Dec; 299(24):1342-4. PubMed ID: 30899
[No Abstract] [Full Text] [Related]
9. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
[TBL] [Abstract][Full Text] [Related]
10. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
12. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
[TBL] [Abstract][Full Text] [Related]
13. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
Finkel S
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
[TBL] [Abstract][Full Text] [Related]
15. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
[TBL] [Abstract][Full Text] [Related]
16. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
Berkowitz JM
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
[TBL] [Abstract][Full Text] [Related]
17. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
Hart WL; Parmley LF
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
[TBL] [Abstract][Full Text] [Related]
18. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
Samuelian JC; Billardon M; Guillou N
Encephale; 1995; 21(2):147-53. PubMed ID: 7781586
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
[TBL] [Abstract][Full Text] [Related]
20. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care].
Chabannes JP; Lemoine P
Therapie; 1990; 45(6):467-70. PubMed ID: 2080484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
